Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Coombe

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Environmental Health|April 11, 1980
Rat bites support need for in-home control: an epidemiologic study of rat bites in New York City, 1974-1978N Coombe, J S Marr
Annals of Internal Medicine|May 1, 1990
Tumor necrosis factor and hypermetabolismT B Seaton, N Coombe, A Mittelman
Urology|March 1, 1994
Urologic complications of high-dose chemotherapy and bone marrow transplantationM D Efros, T Ahmed, N Coombe, et al.
Investigational New Drugs|January 19, 2000
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319)A Mittelman, H G Chun, C Puccio, et al.
Leukemia|April 1, 1994
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomasT Ahmed, P Cook, E Feldman, et al.
Investigational New Drugs|August 1, 1992
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusionA Mittelman, C Puccio, E Gafney, et al.
Acta Haematologica|January 1, 1989
Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhageE J Feldman, Z A Arlin, T Ahmed, et al.
Bone Marrow Transplantation|August 1, 1993
Propantheline prevention of mucositis from etoposideT Ahmed, C Engelking, J Szalyga, et al.
Journal of Clinical Microbiology|October 1, 1989
Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiersS Maoleekoonpairoj, A Mittelman, S Savona, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Environmental Health|April 11, 1980
Rat bites support need for in-home control: an epidemiologic study of rat bites in New York City, 1974-1978N Coombe, J S Marr
Annals of Internal Medicine|May 1, 1990
Tumor necrosis factor and hypermetabolismT B Seaton, N Coombe, A Mittelman
Urology|March 1, 1994
Urologic complications of high-dose chemotherapy and bone marrow transplantationM D Efros, T Ahmed, N Coombe, et al.
Investigational New Drugs|January 19, 2000
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319)A Mittelman, H G Chun, C Puccio, et al.
Leukemia|April 1, 1994
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomasT Ahmed, P Cook, E Feldman, et al.
Investigational New Drugs|August 1, 1992
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusionA Mittelman, C Puccio, E Gafney, et al.
Acta Haematologica|January 1, 1989
Acute promyelocytic leukemia: a 5-year experience with new antileukemic agents and a new approach to preventing fatal hemorrhageE J Feldman, Z A Arlin, T Ahmed, et al.
Bone Marrow Transplantation|August 1, 1993
Propantheline prevention of mucositis from etoposideT Ahmed, C Engelking, J Szalyga, et al.
Journal of Clinical Microbiology|October 1, 1989
Lack of protection against bacterial infections in patients with advanced cancer treated by biologic response modifiersS Maoleekoonpairoj, A Mittelman, S Savona, et al.
Pageof 1